ΓΑΝΟΔΕΡΜΑ ΙΝΟΜΥΩΜΑΤΑ
Παραπομπές
1. Taylor DK, Leppert PC. Treatment for Uterine Fibroids: Searching for Effective Drug Therapies. Drug Discov Today Ther Strateg. 2012;9(1):e41-e49. doi: 10.1016/j.ddstr.2012.06.001. PMID: 23264802; PMCID: PMC3525705.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525705/
2. Zhao S, Ye G, Fu G, Cheng J, Yang BB and Peng C: Ganoderma lucidum exerts anti-tumor effects on ovarian cancer cells and enhances their sensitivity to cisplatin. Int J Oncol 38: 1319-1327, 2011
https://www.spandidos-publications.com/ijo/38/5/1319
3. Geng X, Zhong D, Su L, Lin Z, Yang B. Preventive and therapeutic effect of Ganoderma lucidum on kidney injuries and diseases. Adv Pharmacol. 2020;87:257-276. doi: 10.1016/bs.apha.2019.10.003. Epub 2019 Nov 20. PMID: 32089235.
https://pubmed.ncbi.nlm.nih.gov/32089235/
4. Guo C, Guo D, Fang L, Sang T, Wu J, Guo C, Wang Y, Wang Y, Chen C, Chen J, Chen R, Wang X. Ganoderma lucidum polysaccharide modulates gut microbiota and immune cell function to inhibit inflammation and tumorigenesis in colon. Carbohydr Polym. 2021 Sep 1;267:118231. doi: 10.1016/j.carbpol.2021.118231. Epub 2021 May 20. PMID: 34119183.
https://pubmed.ncbi.nlm.nih.gov/34119183/
5. Kabodmehri R, Etezadi A, Sharami SH, Ghanaei MM, Hosseinzadeh F, Heirati SFD, Pourhabibi Z. The association between chronic endometritis and uterine fibroids. J Family Med Prim Care. 2022 Feb;11(2):653-659. doi: 10.4103/jfmpc.jfmpc_1470_21. Epub 2022 Feb 16. PMID: 35360819; PMCID: PMC8963633.
https://pubmed.ncbi.nlm.nih.gov/35360819/
6. Elkafas H, Badary O, Elmorsy E, Kamel R, Yang Q, Al-Hendy A. Endocrine-Disrupting Chemicals and Vitamin D Deficiency in the Pathogenesis of Uterine Fibroids. J Adv Pharm Res. 2021 Spring;5(2):260-275. doi: 10.21608/aprh.2021.66748.1124. PMID: 34746367; PMCID: PMC8570385.
https://pubmed.ncbi.nlm.nih.gov/34746367/
7. Pavone D, Clemenza S, Sorbi F, Fambrini M, Petraglia F. Epidemiology and Risk Factors of Uterine Fibroids. Best Pract Res Clin Obstet Gynaecol. 2018 Jan;46:3-11. doi: 10.1016/j.bpobgyn.2017.09.004. Epub 2017 Oct 1. PMID: 29054502.
https://pubmed.ncbi.nlm.nih.gov/29054502/
8. Lethaby A, Vollenhoven B. Fibroids (uterine myomatosis, leiomyomas). BMJ Clinical Evidence. 2015 Jun;2015:0814. PMID: 26032466; PMCID: PMC4451527.
https://europepmc.org/article/MED/26032466
9. Wise LA, Laughlin-Tommaso SK. Epidemiology of Uterine Fibroids: From Menarche to Menopause. Clinical Obstetrics and Gynecology. 2016 Mar;59(1):2-24. DOI: 10.1097/grf.0000000000000164. PMID: 26744813; PMCID: PMC4733579.
https://europepmc.org/article/MED/26744813
10. Venkatesh SS, Ferreira T, Benonisdottir S, et al. Obesity and risk of female reproductive conditions: A Mendelian randomisation study. Plos Medicine. 2022 Feb;19(2):e1003679. DOI: 10.1371/journal.pmed.1003679. PMID: 35104295; PMCID: PMC8806071.
https://europepmc.org/article/MED/35104295
11. Expert Panel on GYN and OB Imaging; Ascher SM, Wasnik AP, Robbins JB, Adelman M, Brook OR, Feldman MK, Jones LP, Knavel Koepsel EM, Patel-Lippmann KK, Patlas MN, VanBuren W, Maturen KE. ACR Appropriateness Criteria® Fibroids. J Am Coll Radiol. 2022 Nov;19(11S):S319-S328. doi: 10.1016/j.jacr.2022.09.019. PMID: 36436959.
https://pubmed.ncbi.nlm.nih.gov/36436959/
12. Templeman C, Marshall SF, Clarke CA, et al. Risk factors for surgically removed fibroids in a large cohort of teachers. Fertility and Sterility. 2009 Oct;92(4):1436-1446. DOI: 10.1016/j.fertnstert.2008.08.074. PMID: 19019355; PMCID: PMC2765807.
https://europepmc.org/article/PMC/2765807
13. Jie Lu, Jing Tian, Li Zhou, Lijun Meng, Sitan Chen, Changyang Ma, Jinmei Wang, Zhenhua Liu, Changqin Li, Wenyi Kang, "Phytochemistry and Biological Activities of Poria", Journal of Chemistry, vol. 2021, Article ID 6659775, 20 pages, 2021. https://doi.org/10.1155/2021/6659775
https://www.hindawi.com/journals/jchem/2021/6659775/
1. Taylor DK, Leppert PC. Treatment for Uterine Fibroids: Searching for Effective Drug Therapies. Drug Discov Today Ther Strateg. 2012;9(1):e41-e49. doi: 10.1016/j.ddstr.2012.06.001. PMID: 23264802; PMCID: PMC3525705.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525705/
2. Zhao S, Ye G, Fu G, Cheng J, Yang BB and Peng C: Ganoderma lucidum exerts anti-tumor effects on ovarian cancer cells and enhances their sensitivity to cisplatin. Int J Oncol 38: 1319-1327, 2011
https://www.spandidos-publications.com/ijo/38/5/1319
3. Geng X, Zhong D, Su L, Lin Z, Yang B. Preventive and therapeutic effect of Ganoderma lucidum on kidney injuries and diseases. Adv Pharmacol. 2020;87:257-276. doi: 10.1016/bs.apha.2019.10.003. Epub 2019 Nov 20. PMID: 32089235.
https://pubmed.ncbi.nlm.nih.gov/32089235/
4. Guo C, Guo D, Fang L, Sang T, Wu J, Guo C, Wang Y, Wang Y, Chen C, Chen J, Chen R, Wang X. Ganoderma lucidum polysaccharide modulates gut microbiota and immune cell function to inhibit inflammation and tumorigenesis in colon. Carbohydr Polym. 2021 Sep 1;267:118231. doi: 10.1016/j.carbpol.2021.118231. Epub 2021 May 20. PMID: 34119183.
https://pubmed.ncbi.nlm.nih.gov/34119183/
5. Kabodmehri R, Etezadi A, Sharami SH, Ghanaei MM, Hosseinzadeh F, Heirati SFD, Pourhabibi Z. The association between chronic endometritis and uterine fibroids. J Family Med Prim Care. 2022 Feb;11(2):653-659. doi: 10.4103/jfmpc.jfmpc_1470_21. Epub 2022 Feb 16. PMID: 35360819; PMCID: PMC8963633.
https://pubmed.ncbi.nlm.nih.gov/35360819/
6. Elkafas H, Badary O, Elmorsy E, Kamel R, Yang Q, Al-Hendy A. Endocrine-Disrupting Chemicals and Vitamin D Deficiency in the Pathogenesis of Uterine Fibroids. J Adv Pharm Res. 2021 Spring;5(2):260-275. doi: 10.21608/aprh.2021.66748.1124. PMID: 34746367; PMCID: PMC8570385.
https://pubmed.ncbi.nlm.nih.gov/34746367/
7. Pavone D, Clemenza S, Sorbi F, Fambrini M, Petraglia F. Epidemiology and Risk Factors of Uterine Fibroids. Best Pract Res Clin Obstet Gynaecol. 2018 Jan;46:3-11. doi: 10.1016/j.bpobgyn.2017.09.004. Epub 2017 Oct 1. PMID: 29054502.
https://pubmed.ncbi.nlm.nih.gov/29054502/
8. Lethaby A, Vollenhoven B. Fibroids (uterine myomatosis, leiomyomas). BMJ Clinical Evidence. 2015 Jun;2015:0814. PMID: 26032466; PMCID: PMC4451527.
https://europepmc.org/article/MED/26032466
9. Wise LA, Laughlin-Tommaso SK. Epidemiology of Uterine Fibroids: From Menarche to Menopause. Clinical Obstetrics and Gynecology. 2016 Mar;59(1):2-24. DOI: 10.1097/grf.0000000000000164. PMID: 26744813; PMCID: PMC4733579.
https://europepmc.org/article/MED/26744813
10. Venkatesh SS, Ferreira T, Benonisdottir S, et al. Obesity and risk of female reproductive conditions: A Mendelian randomisation study. Plos Medicine. 2022 Feb;19(2):e1003679. DOI: 10.1371/journal.pmed.1003679. PMID: 35104295; PMCID: PMC8806071.
https://europepmc.org/article/MED/35104295
11. Expert Panel on GYN and OB Imaging; Ascher SM, Wasnik AP, Robbins JB, Adelman M, Brook OR, Feldman MK, Jones LP, Knavel Koepsel EM, Patel-Lippmann KK, Patlas MN, VanBuren W, Maturen KE. ACR Appropriateness Criteria® Fibroids. J Am Coll Radiol. 2022 Nov;19(11S):S319-S328. doi: 10.1016/j.jacr.2022.09.019. PMID: 36436959.
https://pubmed.ncbi.nlm.nih.gov/36436959/
12. Templeman C, Marshall SF, Clarke CA, et al. Risk factors for surgically removed fibroids in a large cohort of teachers. Fertility and Sterility. 2009 Oct;92(4):1436-1446. DOI: 10.1016/j.fertnstert.2008.08.074. PMID: 19019355; PMCID: PMC2765807.
https://europepmc.org/article/PMC/2765807
13. Jie Lu, Jing Tian, Li Zhou, Lijun Meng, Sitan Chen, Changyang Ma, Jinmei Wang, Zhenhua Liu, Changqin Li, Wenyi Kang, "Phytochemistry and Biological Activities of Poria", Journal of Chemistry, vol. 2021, Article ID 6659775, 20 pages, 2021. https://doi.org/10.1155/2021/6659775
https://www.hindawi.com/journals/jchem/2021/6659775/
